Homeopathy assuages side effects of Rx

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 5
Volume 18
Issue 5

Homeopathy can help cancer patients with skin irritation and mouth sores, according to a review involving 664 participants published in the Cochrane Database of Systematic Reviews (online issue 2, 2009).

Homeopathy can help cancer patients with skin irritation and mouth sores, according to a review involving 664 participants published in the Cochrane Database of Systematic Reviews (online issue 2, 2009).

Sosie Kassab, MD, director of the Royal London Homeopathic Hospital’s Complementary Cancer Service, and colleagues reviewed eight studies on homeopathic remedies.

In one study with 256 participants, researchers found skin irritation from radiotherapy was less in patients who used calendula ointment as opposed to the topical agent trolamine. In another study with 32 participants, the hemeopathic, Traumeel S, relieved mouth sores caused by chemotherapy better than placebo.

There is no convincing evidence to support the use of homeopathic medicines for adverse effects of cancer treatments other than skin irritation and mouth sores, Dr. Kassab said. “But very little research has been undertaken and more is required,” she said.

Most physicians are unaware that major, federally funded clinical trials on alternative medicine are currently underway (Arch Intern Med 169:670-679, 2009).

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content